Related scientific articles (all)

The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-Technology.

Authors : Albisinni S, Oderda M, Fossion L, Varca V, Rassweiler J, Cathelineau X, Chlosta P, de La Taille A, Gaboardi F, Piechaud T, Rimington P, Salomon L, Sanchez-Salas R, Stolzenburg JU, Teber D, Van Velthoven R
Year : 2016
Journal : World J Urol
Volume : 34(2)
Pages : 149-56

Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy.

Authors : Johnson DB, Estrada MV, Salgado R, Sanchez V, Doxie DB, Opalenik SR, Vilgelm AE, Feld E, Johnson AS, Greenplate AR, Sanders ME, Lovly CM, Frederick DT, Kelley MC, Richmond A, Irish JM, Shyr Y, Sullivan RJ, Puzanov I, Sosman JA, Balko JM
Year : 2016
Journal : Nat Commun
Volume : 7
Pages : 10582

Euthanasia 2002-2014: The situation in Belgium.

Authors : Lossignol D
Year : 2016
Journal : Rev Mal Respir
Volume : 33(8)
Pages : 692-702

Immune checkpoint inhibitors side effects and management.

Authors : Kourie HR, Klastersky J
Year : 2016
Journal : Immunotherapy
Volume : 8
Pages : 799-807

Interval Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in First-Line Treatment for Advanced Ovarian Carcinoma: A Feasibility Study.

Authors : Dhondt V, Goffin F, Roca L, Dresse D, Leroy C, Kerger J, Cordier L, de Forges H, Veys I, Liberale G
Year : 2016
Journal : Int J Gynecol Cancer
Volume : 26(5)
Pages : 912-7

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.

Authors : Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV Jr, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y
Year : 2016
Journal : ESMO Open
Volume : 1
Pages : e000097

Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.

Authors : Antoine C, Ameye L, Paesmans M, de Azambuja E, Rozenberg S
Year : 2016
Journal : Maturitas
Volume : 84
Pages : 81-8

What is the role of informed decision-making?

Authors : Pondé N, Dal Lago L, Azim HA Jr
Year : 2016
Journal : Expert Rev Anticancer Ther
Volume : 16(9)
Pages : 893

Pancreatic small cell cancer.

Authors : El Rassy E, Tabchi S, Kourie HR, Assi T, Chebib R, Farhat F, Kattan J
Year : 2016
Journal : Clin Res Hepatol Gastroenterol
Volume : 40
Pages : 276-80

Faut-il réévaluer les indications pour l’utilisation des facteurs stimulant la granulopoïèse en fonction des comorbidités présentées par les patients?

Authors : Klastersky J, Paesmans M
Year : 2016
Journal : Onco-Hémato
Volume : -
Pages : 4 pages

Le mot du Rédacteur en Chef

Authors : Berghmans T
Year : 2016
Journal : Rev Med Brux
Volume : 37
Pages : 129

Understanding the risk for infection in patients with neutropenia.

Authors : Klastersky J, Meert AP
Year : 2016
Journal : Intensive Care Med
Volume : 42(2)
Pages : 268-70

Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer.

Authors : Twelves C, Jove M, Gombos A, Awada A
Year : 2016
Journal : Crit Rev Oncol Hematol
Volume : 100
Pages : 74-87

Learning from the tsunami" of immune checkpoint inhibitors in 2015."

Authors : Kourie HR, Awada G, Awada A
Year : 2016
Journal : Crit Rev Oncol Hematol
Volume : 101
Pages : 213-220

Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.

Authors : Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro J, OConnor D, Oliver K, Piault-Louis E, Piccart-Gebhart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C, Smith AW, Soltys KM, Taphoorn MJ, Velikova G, Coens C
Year : 2016
Journal : Lancet Oncol
Volume : 17
Pages : e510-e514

The current use and attitudes towards tumor genome sequencing in breast cancer.

Authors : Gingras I, Sonnenblick A, de Azambuja E, Paesmans M, Delaloge S, Aftimos P, Piccart-Gebhart M, Sotiriou C, Ignatiadis M, Azim HA Jr
Year : 2016
Journal : Sci Rep
Volume : 6
Pages : 22517

Clinical relevance of host immunity in breast cancer: from TILs to the clinic.

Authors : Savas P, Salgado R, Denkert C, Sotiriou C, Darcy PK, Smyth MJ, Loi S
Year : 2016
Journal : Nat Rev Clin Oncol
Volume : 13(4)
Pages : 228-41

Multidisciplinary questions in thoracic oncology: the team experience.

Authors : Sculier JP
Year : 2016
Journal : Eur Respir J
Volume : 48
Pages : 626-7

Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer.

Authors : Lamartina L, Grani G, Biffoni M, Giacomelli L, Costante G, Lupo S, Maranghi M, Plasmati K, Sponziello M, Trulli F, Verrienti A, Filetti S, Durante C
Year : 2016
Journal : J Clin Endocrinol Metab
Volume : 101(8)
Pages : 3036-44

Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors.

Authors : Levacq D, DHaene N, de Wind R, Remmelink M, Berghmans T
Year : 2016
Journal : Lung Cancer
Volume : 102
Pages : 38-41